Physician profile
Heidi Godoy
NPI 1851786834
$42,760.40
in general payments reported to CMS, 2019-2025
31 companies · $2,594 in 2025
The $2,594 reported for 2025 was more than what 87% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $463 · 2021: $5,182 · 2022: $14K · 2023: $7,300 · 2024: $2,831 · 2025: $2,594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,705 · Travel and Lodging: $6,019.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,705.22 |
| Travel and Lodging | $6,019.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $12,077.94 | 2019-2025 | Inbone, Prophecy, Augment Injectable |
| Arthrex, INC. | $9,447.92 | 2019-2023 | |
| Seapearl East, INC | $9,248.84 | 2019-2024 | |
| Paragon 28, INC. | $4,377.98 | 2022-2025 | Monkey Rings, Portfolio, Precision Mis Bunion |
| Orthofix Medical, INC. | $3,161.81 | 2019-2025 | Physio-Stim |
| Treace Medical Concepts, INC. | $1,641.24 | 2022-2025 | |
| Organogenesis INC. | $398.77 | 2024-2025 | Affinity, Puraply Am, Apligraf |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $393.66 | 2020-2025 | Jublia |
| Kerecis Limited | $265.36 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Acera Surgical, INC. | $225.12 | 2024-2025 | Restrata Wound Matrix |
| Integra Lifesciences Corporation | $178.01 | 2019-2025 | Tcc-Ez |
| Novastep INC. | $160.96 | 2025 | Nexis |
| Extremity Medical | $158.37 | 2024 | |
| Suvon Surgical LLC | $131.77 | 2023 | |
| Zimmer Biomet Holdings, INC. | $126.01 | 2022-2025 | Tapestry |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Liberty Surgical INC. | $118.97 | 2019 | |
| Smith+Nephew, INC. | $116.07 | 2022-2025 | Collagenase Santyl, Grafix Pl, Stravix Pl |
| Nuvasive Specialized Orthopedics, INC. | $92.62 | 2019 | |
| Cardiovascular Systems INC. | $79.55 | 2021 | |
| Sebela Pharmaceuticals INC. | $69.54 | 2022-2023 | Pramosone, Naftin |
| Urgo Medical North America, LLC | $64.43 | 2024-2025 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Convatec INC. | $39.50 | 2023 | |
| Medshape, INC. | $31.82 | 2023 | Dynanail, Dynaclip Bone Fixation System, Quattro, 22mm X 20mm X 20mm |
| Djo, LLC | $24.57 | 2025 | Dr Comfort |
| Medtronic, INC. | $23.06 | 2022 | |
| Nevro Corp. | $18.70 | 2023 | Senza |
| Paratek Pharmaceuticals, INC. | $18.62 | 2024 | Nuzyra |
| Musculoskeletal Transplant Foundation INC. | $18.33 | 2025 | |
| Zimvie INC. | $17.77 | 2022 | |
| Trilliant Surgical LLC. | $17.69 | 2022 | |
| Terumo Bct, INC. | $15.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Godoy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.